In this article (Cancer Immunol Res 2014;2:632–42), which appeared in the July 2014 issue of Cancer Immunology Research (1), the panels of Fig. 1 are labeled incorrectly. The grade 4 toxicities should be labeled as A, and the grade 3 toxicities as B; B to G should be labeled C to H. The authors regret this error.
References
1.
Hodi
FS
, Lawrence
D
, Lezcano
C
, Wu
X
, Zhou
J
, Sasada
T
, et al Bevacizumab plus ipilimumab in patients with metastatic melanoma
. Cancer Immunol Res
2014
;2
:632
–42
.©2014 American Association for Cancer Research.
2014